These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 18401811)

  • 41. Is it legal? Prescribing for the athlete.
    Sando BG
    Aust Fam Physician; 1999 Jun; 28(6):549-53. PubMed ID: 10399386
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Popular drugs in sport: descriptive analysis of the enquiries made via the Drug Information Database (DID).
    Petróczi A; Naughton DP
    Br J Sports Med; 2009 Oct; 43(11):811-7. PubMed ID: 18981038
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dietary supplementation of high-performance Canadian athletes by age and gender.
    Erdman KA; Fung TS; Doyle-Baker PK; Verhoef MJ; Reimer RA
    Clin J Sport Med; 2007 Nov; 17(6):458-64. PubMed ID: 17993788
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Doping, drugs and drug abuse among adolescents in the State of Thuringia (Germany): prevalence, knowledge and attitudes.
    Wanjek B; Rosendahl J; Strauss B; Gabriel HH
    Int J Sports Med; 2007 Apr; 28(4):346-53. PubMed ID: 17024651
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use/misuse of over-the-counter medications and associated adverse drug events among HIV-infected patients.
    Ajuoga E; Sansgiry SS; Ngo C; Yeh RF
    Res Social Adm Pharm; 2008 Sep; 4(3):292-301. PubMed ID: 18794039
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of reading additional safety information on planned use of over-the-counter analgesics.
    McDonald DD; Amendola MG; Interlandi E; Wall K; Lewchik B; Polouse L; Pace N; Inthavong S; Li L
    Public Health Nurs; 2007; 24(3):230-8. PubMed ID: 17456124
    [TBL] [Abstract][Full Text] [Related]  

  • 47. History of mass spectrometry at the Olympic Games.
    Hemmersbach P
    J Mass Spectrom; 2008 Jul; 43(7):839-53. PubMed ID: 18570181
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Can we measure accurately the prevalence of doping?
    Lentillon-Kaestner V; Ohl F
    Scand J Med Sci Sports; 2011 Dec; 21(6):e132-42. PubMed ID: 22126721
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Health beliefs and over-the-counter product use.
    Häussinger C; Ruhl UE; Hach I
    Ann Pharmacother; 2009 Jun; 43(6):1122-7. PubMed ID: 19470857
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of asthma-like symptoms, asthma and its treatment in elite athletes.
    Lund T; Pedersen L; Larsson B; Backer V
    Scand J Med Sci Sports; 2009 Apr; 19(2):174-8. PubMed ID: 18282226
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Doping and sports].
    Lippi G; Guidi G
    Minerva Med; 1999 Sep; 90(9):345-57. PubMed ID: 10719440
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of mouthguard rates among university athletes during sport activities in Erzurum, Turkey.
    Yeşil Duymuş Z; Gungor H
    Dent Traumatol; 2009 Jun; 25(3):318-22. PubMed ID: 19302200
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Knowledge, attitudes and practices of anabolic steroid usage among gym users in Trinidad.
    Maharaj VR; Dookie T; Mohammed S; Ince S; Marsang BL; Rambocas N; Chin M; McDougall L; Teelucksingh S
    West Indian Med J; 2000 Mar; 49(1):55-8. PubMed ID: 10786454
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ESC study group of sports cardiology position paper on adverse cardiovascular effects of doping in athletes.
    Deligiannis A; Björnstad H; Carre F; Heidbüchel H; Kouidi E; Panhuyzen-Goedkoop NM; Pigozzi F; Schänzer W; Vanhees L;
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):687-94. PubMed ID: 17001206
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predicting attitude towards performance enhancing substance use: a comprehensive test of the Sport Drug Control Model with elite Australian athletes.
    Jalleh G; Donovan RJ; Jobling I
    J Sci Med Sport; 2014 Nov; 17(6):574-9. PubMed ID: 24268440
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The prevalence of trimetazidine use in athletes in Poland: excretion study after oral drug administration.
    Jarek A; Wójtowicz M; Kwiatkowska D; Kita M; Turek-Lepa E; Chajewska K; Lewandowska-Pachecka S; Pokrywka A
    Drug Test Anal; 2014; 6(11-12):1191-6. PubMed ID: 25421604
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Androgenic-anabolic steroids and the Olympic Games.
    Fitch KD
    Asian J Androl; 2008 May; 10(3):384-90. PubMed ID: 18385900
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ample use of physician-prescribed medications in Finnish elite athletes.
    Alaranta A; Alaranta H; Heliövaara M; Airaksinen M; Helenius I
    Int J Sports Med; 2006 Nov; 27(11):919-25. PubMed ID: 16586342
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug testing in sport: the attitudes and experiences of elite athletes.
    Dunn M; Thomas JO; Swift W; Burns L; Mattick RP
    Int J Drug Policy; 2010 Jul; 21(4):330-2. PubMed ID: 20079619
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Knowledge, attitudes, and behaviour of the population of the Czech Republic to self-medication. III: behaviour in the area of drugs and self-medication].
    Drhová L
    Ceska Slov Farm; 2005 Sep; 54(5):211-8. PubMed ID: 16209435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.